secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZIMMER BIOMET HOLDINGS, INC. (ZBH)
CIK:        0001136869
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0000950170-25-063124
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Zimmer Biomet Q1 rev +1.1%; guides 2025 adj EPS down to $7.90-$8.10, rev up including Paragon 28
--------------------------------------------------------------------------------

- Q1 net sales $1.909B (+1.1% reported, +2.3% CC); GAAP EPS $0.91, adjusted EPS $1.81.
- 2025 adjusted EPS guidance lowered to $7.90-$8.10 from $8.15-$8.35 due to Paragon 28, currency, and tariffs.
- 2025 reported revenue guidance raised to 5.7%-8.2% (includes Paragon 28); organic CC unchanged at 3%-5%.
- Completed acquisition of Paragon 28 (foot and ankle orthopedics) in Q1 2025.
- Chairman Begley retiring at May 29 meeting; CEO Tornos to become Chairman, Farrell Lead Independent Director.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1136869/000095017025063124/0000950170-25-063124-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1136869/000095017025063124/zbh-20250505.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-063124

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer